Project description
Chemical safety assessment without animal testing
The EU aims to promote alternative methods to animal testing. EU-funded PrecisionTox proposes 'precision toxicology', a novel scientific approach establishing causation between chemicals and their adverse health effects. The project focuses on human cell lines and a diverse suite of biomedical model organisms, i.e. fruit flies, water fleas, round worms and embryos of zebrafish and frogs, which share many genes with humans by evolution. These 3Rs compliant, cost-effective testing models enable the mapping of origins of toxicity pathways on the branches of the animal evolutionary tree to predict health risks to humans. By providing data where the toxicity of substances is unknown, PrecisionTox will ultimately translate into regulatory and industrial practices that better protect human health and the environment.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
B15 2TT Birmingham
United Kingdom
See on map
Participants (14)
69117 Heidelberg
See on map
47402 Bloomington
See on map
76131 Karlsruhe
See on map
08003 Barcelona
See on map
91000 Evry
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
29634 Clemson
See on map
OX1 2JD Oxford
See on map
04318 Leipzig
See on map
1050 Ixelles
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
69120 Heidelberg
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
CV12NT Coventry
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
08225 Terrassa
See on map
20520 Turku
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1010 Riga
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.